EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Chandra Bhagat Pharma's Enterprise Value is ₹1,073 Mil.
Chandra Bhagat Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was ₹67 Mil. Therefore, Chandra Bhagat Pharma's EV-to-FCF for today is 15.94.
The historical rank and industry rank for Chandra Bhagat Pharma's EV-to-FCF or its related term are showing as below:
BOM:542934'
s EV-to-FCF Range Over the Past 10 Years
Min: -7.8 Med: 8.54 Max: 25.3
Current: 15.84
During the past 7 years, the highest EV-to-FCF of Chandra Bhagat Pharma was 25.30. The lowest was -7.80. And the median was 8.54.
BOM:542934's EV-to-FCF is ranked better than 65.06% of 518
companies
in the Drug Manufacturers industry
Industry Median: 24.625
vs BOM:542934: 15.84
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Chandra Bhagat Pharma's EV-to-FCF
For the Drug Manufacturers - Specialty & Generic subindustry, Chandra Bhagat Pharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chandra Bhagat Pharma's EV-to-FCF Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Chandra Bhagat Pharma's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Chandra Bhagat Pharma's EV-to-FCF falls into.
Chandra Bhagat Pharma's current Enterprise Value is ₹1,073 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Chandra Bhagat Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was ₹67 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Chandra Bhagat Pharma's PE Ratio for today is calculated as:
Chandra Bhagat Pharma's share price for today is ₹120.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Chandra Bhagat Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was ₹1.550.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Chandra Bhagat Pharma EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Chandra Bhagat Pharma's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Chandra Bhagat Pharma (BOM:542934) Business Description
Chandra Bhagat Pharma Ltd is engaged in the business of marketing pharmaceutical critical care and health care products. The company provides a pharmaceutical formulation in therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology, and others. It is also engaged in promoting and marketing Active Pharmaceuticals Ingredients (APIs) in India.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:542934 has been successfully added to your 